Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with ...

Chemists at Université de Montréal have developed "signaling cascades" made with DNA molecules to report and quantify the ...

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...

A study published in Science reveals a cellular mechanism involved in the inheritance of genetic mutations. The study also ...

Scientists developed a fast DNA damage test for radiation that could guide cancer care and help responders deliver personalized treatment during radiological emergencies. (Nanowerk News) Scientists at ...

EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.

Inspired by living cells, researchers have designed DNA molecules that allow drug concentrations in blood to be measured ...

New research found that gene therapy for children with "bubble boy disease," or SCID, was successful in 95% of trial ...